Form 8-K · Current report
Rockwell Automation 8-K, filed Nov 5, 2026
- Filed
- CIK
- 0001024478
- Accession no.
- 0001024478-26-000045
Summary
Rockwell Automation reported fiscal 2026 fourth-quarter sales of $2.33 billion, up 1% reported and 3% organically, and full-year sales of $8.99 billion, up 8%, alongside adjusted EPS of $3.88 for the quarter and $13.42 for the year. The company introduced fiscal 2027 guidance of 4.5%–7.5% reported sales growth and adjusted EPS of $14.50–$15.50, with CEO Blake Moret citing healthy customer demand and new product releases.
Key points
- Fourth-quarter net income attributable to Rockwell was $346 million, or $3.11 per diluted share, versus $138 million, or $1.23, a year earlier.
- Full-year fiscal 2026 operating cash flow was $1,958 million and free cash flow $1,701 million, up 27% and 25%.
- Rockwell received $103 million of IEEPA tariff refunds plus $5 million of related interest, and accrued $85 million for a customer tariff refund program that reduced reported sales.
- Fiscal 2027 guidance includes organic sales growth of 6%–9% and diluted EPS of $13.78–$14.78.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. Registrant's press release dated November 5, 2026, announcing its financial results for the year ended September 30, 2026, is furnished herewith as Exhibit 99 and is incorporated herein by reference. Item 9.01. Financial Statements and Exhibits. Exhibit Number Description 99 Press Release of Registrant dated November 5, 2026. 104 Cover Page Interactive Data File, formatted in inline XBRL. Exhibit 99: EX-99 2 fy2026ex99.htm EX-99 Exhibit 99 1201 S. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.